These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32055741)

  • 21. Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
    Li G; Xie J; Chen J; Li R; Wu H; Zhang X; Chen Q; Gu R; Xu B
    Cardiovasc Pathol; 2017; 28():74-79. PubMed ID: 28395201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats.
    Zhao J; Yu QX; Kong W; Gao HC; Sun B; Xie YQ; Ren LQ
    Exp Ther Med; 2013 Jun; 5(6):1765-1769. PubMed ID: 23837070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
    Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
    J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
    Yamada S; Kane GC; Behfar A; Liu XK; Dyer RB; Faustino RS; Miki T; Seino S; Terzic A
    J Physiol; 2006 Dec; 577(Pt 3):1053-65. PubMed ID: 17038430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel aldosterone synthase inhibitor ameliorates mortality in pressure-overload mice with heart failure.
    Furuzono S; Meguro M; Miyauchi S; Inoue S; Homma T; Yamada K; Tagawa YI; Nara F; Nagayama T
    Eur J Pharmacol; 2017 Jan; 795():58-65. PubMed ID: 27915044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
    Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
    Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines.
    Ziltener P; Mueller C; Haenig B; Scherz MW; Nayler O
    J Recept Signal Transduct Res; 2002; 22(1-4):155-68. PubMed ID: 12503613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
    Higashikuni Y; Sainz J; Nakamura K; Takaoka M; Enomoto S; Iwata H; Tanaka K; Sahara M; Hirata Y; Nagai R; Sata M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):654-61. PubMed ID: 22116099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
    Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
    J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
    Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
    Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
    Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
    J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine improved left ventricular function and pressure overload-induced cardiomyocyte apoptosis in a transverse aortic constriction mouse model.
    Yu Y; Hu Z; Li B; Wang Z; Chen S
    Mol Cell Biochem; 2019 Jan; 450(1-2):25-34. PubMed ID: 29790114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8
    Gröschel C; Sasse A; Monecke S; Röhrborn C; Elsner L; Didié M; Reupke V; Bunt G; Lichtman AH; Toischer K; Zimmermann WH; Hasenfuß G; Dressel R
    Front Immunol; 2018; 9():2665. PubMed ID: 30498501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
    Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice.
    Wang Z; Xu Y; Wang M; Ye J; Liu J; Jiang H; Ye D; Wan J
    EBioMedicine; 2018 Oct; 36():54-62. PubMed ID: 30297144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.